Identifying target molecules typically involves biomarker discovery and validation processes. Researchers use techniques such as genomics, proteomics, and bioinformatics to identify molecules that are uniquely expressed or altered in disease states. High-throughput screening and computational modeling are also employed to predict and validate potential target molecules.
